Table 4 Age-dependent seroprevalence of HSV-1 and HSV-2, Vaud-Fribourg, 1992–3, Women
HSV-1 | HSV-2 | ||||||
|---|---|---|---|---|---|---|---|
Age group | n | Rate seropositive (±SE, 95% CI) | Odds Ratio (95%CI) | P value | Rate seropositive (±SE, 95% CI) | Odds Ratio (95%CI) | P value |
25–34 | 204 | 69.1 ± 3.2% (62.8–75.5) | 0.54 (0.35–0.85) | 0.008 | 12.2 ± 2.3% (7.7–16.8) | 0.47 (0.28–0.81) | 0.006 |
35–44 | 237 | 77.2 ± 2.7% (71.9–82.6) | 0.81 (0.51–1.29) | 0.376 | 17.3 ± 2.5% (12.5–22.1) | 0.71 (0.44–1.14) | 0.154 |
45–54 a | 202 | 80.7 ± 2.8% (75.2–86.1) | 1.00 (---) | --- | 22.8 ± 3.0% (17.0–28.6) | 1.00 (---) | --- |
55–64 | 126 | 84.9 ± 3.2% (78.6–91.2) | 1.35 (0.74–2.46) | 0.332 | 19.0 ± 3.5% (12.2–25.9) | 0.80 (0.46–1.39) | 0.426 |
65–74 | 100 | 84.0 ± 3.7% (76.8–91.2) | 1.26 (0.66–2.39) | 0.486 | 17.0 ± 3.8% (9.6–24.4%) | 0.69 (0.37–1.29) | 0.249 |
Total | 869 | 77.9 ± 1.4% (75.2–80.7) | --- | --- | 17.3 ± 1.3% (14.8–19.8) | --- | --- |